Expression of the MDR1 Gene and Treatment Outcome in Acute Nonlymphocytic Leukemia

Robert Pirker,Josef Wallner,Klaus Geissler,Peter Bettelheim,W. Linkesch,Klaus Lechner

Expression of the MDR1 Gene and Treatment Outcome in Acute Nonlymphocytic Leukemia

1992

Robert Pirker
Josef Wallner
Klaus Geissler
Peter Bettelheim
W. Linkesch
Klaus Lechner

Drug resistance contributes to the poor prognosis of acute nonlymphocytic leukemia (ANLL) [1, 2]. In order to overcome drug resistance, knowledge of its exact nature is required.

Keywords:

Drug resistance
Leukemia
Precursor cell
Cancer research
Gene
Medicine
poor prognosis
mdr1 gene
Oncology
Internal medicine
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations